Endpoints News 2026-02-26 Protagonist to opt out of Takeda profit-sharing deal, will receive $400M in cash
Endpoints News 2026-02-26 Novartis to build another radioligand factory; Germany steps up probe into Gerresheimer
Endpoints News 2026-02-26 OrbiMed jumps to number one on the top 100 list of biotech venture investors
Endpoints News 2026-02-25 Make way, Camzyos: Cytokinetics touts promising early launch for rival heart drug
Endpoints News 2026-02-25 Polymer nanoparticle startup BreezeBio raises $60M for mRNA diabetes therapy